Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.

Site Map

Site Map of http://www.researchandmarkets.com


Site Map
Pharmaceuticals and Healthcare
   Pharmaceuticals 1 (Latest Titles)
   Pharmaceuticals 2
   Pharmaceuticals 3
   Pharmaceuticals 4

      Central Nervous System  << You are in This Category




#  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  


A

Alzheimer Disease - New Drugs, Markets and Companies static version printer friendly pdf version
Alzheimer’s and Parkinson’s Disease - Global Strategic Business Report  static version printer friendly pdf version
Amyotrophic Lateral Sclerosis: A route to larger CNS markets? static version printer friendly pdf version
Amyotrophic Lateral Sclerosis: A route to larger CNS markets? static version printer friendly pdf version
Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application - 2 Volume Set static version printer friendly pdf version
Arthritis in the United States static version printer friendly pdf version
Autism: An Integrated View from Neurocognitive, Clinical and Intervention Research static version printer friendly pdf version


^ Top



B

Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market static version printer friendly pdf version
Blood-Brain Barriers: From Ontogeny to Artificial Interfaces, Two Volumes static version printer friendly pdf version
Brain metastases static version printer friendly pdf version
Building a Diabetes Medical Home: The Impact on Practice Work Flow, Patient Outcomes and Healthcare Costs, a 90-minute webinar on CD-ROM static version printer friendly pdf version


^ Top



C

Central Nervous System - Alzheimer Disease Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Anxiety Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Dementia Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Depression Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Epilepsy Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Headache Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Migraine static version printer friendly pdf version
Central Nervous System - Migraine Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Multiple Sclerosis Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Neuropathy Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Pain Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Parkinson Disease Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Schizophrenia Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Seizures Drug Pipeline Report static version printer friendly pdf version
Central Nervous System - Stroke Drug Pipeline Report static version printer friendly pdf version
Central Nervous System Alzheimer Disease  static version printer friendly pdf version
Central Nervous System Anxiety  static version printer friendly pdf version
Central Nervous System Attention Deficit Disorder with Hyperactivity  static version printer friendly pdf version
Central Nervous System Dementia  static version printer friendly pdf version
Central Nervous System Depression  static version printer friendly pdf version
Central Nervous System Epilepsy  static version printer friendly pdf version
Central Nervous System Headache  static version printer friendly pdf version
Central Nervous System Insomnia or Sleep Disorders  static version printer friendly pdf version
Central Nervous System Memory Impairment  static version printer friendly pdf version
Central Nervous System Multiple Sclerosis static version printer friendly pdf version
Central Nervous System Neuropathy  static version printer friendly pdf version
Central Nervous System Pain  static version printer friendly pdf version
Central Nervous System Parkinson Disease  static version printer friendly pdf version
Central Nervous System Psychotic Disorders  static version printer friendly pdf version
Central Nervous System Schizophrenia  static version printer friendly pdf version
Central Nervous System Seizures  static version printer friendly pdf version
Central Nervous System Stroke  static version printer friendly pdf version
Clinical Trials in Psychiatry, 2nd Edition static version printer friendly pdf version
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter static version printer friendly pdf version
CNS Drug Discoveries: Depression Chapter static version printer friendly pdf version
CNS Drug Discoveries: Multiple Sclerosis Chapter static version printer friendly pdf version
CNS Drug Discoveries: Neurodegenerative Disorders Chapter static version printer friendly pdf version
CNS Drug Discoveries: Schizophrenia (Chapter) static version printer friendly pdf version
CNS Drug Discoveries: What the Future Holds static version printer friendly pdf version
CNS Drug Discoveries: What The Future Holds Sleep Disorders Chapter static version printer friendly pdf version
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study static version printer friendly pdf version
CNS European Market Competitive Strategies - Competitive Analysis, Profiles and Portfolio Strategies of the Top 20 CNS Therapeutic Manufacturers in Europe (2001 Edition) static version printer friendly pdf version
CNS Market Analysis 2002: Commercial Viability of Four Dynamic CNS Markets static version printer friendly pdf version
CNS Market: Year in Review - Sales Overview and Market News, 2000 static version printer friendly pdf version
CNS Therapeutics - Global Strategic Business Report static version printer friendly pdf version
CNS Therapy US Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles static version printer friendly pdf version
CNS Therapy Worldwide Market Survey: Analysis and Forecasts - Technology, Sales and Company Profiles static version printer friendly pdf version
CNS Year in Review: 2001 static version printer friendly pdf version
Commercial Insight: CNS Market Overview - Commercial Dynamics And Outlook Of The Neurology, Pain And Psychiatry Market Sectors static version printer friendly pdf version
Commercial Insight: Epilepsy - Companies Committed to the Cause will Reap the Benefits static version printer friendly pdf version
Commercial Insight: Parkinsons Disease - Increased Focus on Earlier Treatment and Managing Levodopa Complications Will Drive Market Growth static version printer friendly pdf version
Cox-ii Inhibitors: Comparison of Global Markets and Factors Influencing Performance static version printer friendly pdf version


^ Top



D

Disease and Therapy Review: Back Pain static version printer friendly pdf version
Disease and Therapy Review: Epilepsy static version printer friendly pdf version
Disease and Therapy Review: Parkinsons Disease static version printer friendly pdf version
Does the Treatment of Huntingtons Disease Represent a Commercial Opportunity? static version printer friendly pdf version
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies static version printer friendly pdf version
Drug Discovery for Nervous System Diseases static version printer friendly pdf version
Drugs in Development for Neurological Disorders, 2003 static version printer friendly pdf version
Drugs of Tommorrow 2002: Pain static version printer friendly pdf version
Drugs of Tomorrow 2001: Depression - A Future Away From Serotonin? static version printer friendly pdf version
Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class on Acute Treatment Market static version printer friendly pdf version
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success static version printer friendly pdf version
Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect profile static version printer friendly pdf version


^ Top



E

Emerging Pharmacological Tools in Clinical Neurology static version printer friendly pdf version
Emerging Technologies in Drug Delivery Devices and Implantable Pain Management static version printer friendly pdf version
Epidemiology: Osteo and Rheumatoid Arthritis - Defining the patient populations static version printer friendly pdf version
European Spinal Fusion Products Market, 2005-2011 static version printer friendly pdf version


^ Top



G

Glial Neurobiology static version printer friendly pdf version


^ Top



H

Handbook of Psychiatric Drugs static version printer friendly pdf version
Hippocampal Place Fields: Relevance to Learning and Memory static version printer friendly pdf version


^ Top



I

Interferon Current Market Dynamics & Future Outlook static version printer friendly pdf version


^ Top



M

MarketWatch: CNS static version printer friendly pdf version
MarketWatch: CNS static version printer friendly pdf version
MarketWatch: CNS static version printer friendly pdf version
MarketWatch: Insight into Key Events in CNS Industry static version printer friendly pdf version
Marketwatch: Insight Into Key Events In The CNS Industry static version printer friendly pdf version
Multiple Sclerosis: Continued efforts to extend product lifecycles static version printer friendly pdf version


^ Top



N

Neurodegenerative Disease: The Growing Market for Drugs used in the Treatment of Alzheimer's, Parkinson's and other Neurodegenerative Conditions static version printer friendly pdf version
Neurological and Psychiatric Diseases: Pharmacological Treatments and Commercial Outlook in an Aging Population static version printer friendly pdf version
Neurological Monitors Market, 1998-2008 static version printer friendly pdf version
Neuroprotection - Drugs, Markets and Companies static version printer friendly pdf version


^ Top



O

Orphan Diseases in the CNS Market static version printer friendly pdf version


^ Top



P

Pain Diagnosis - Issues Impact the Pharmaceutical Industry static version printer friendly pdf version
Pain Therapeutics: A Strategic Re-evaluation. static version printer friendly pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Central Nervous System static version printer friendly pdf version
PharmaWatch: CNS static version printer friendly pdf version
Pipeline and Commercial Insight: Alzheimers Disease - Scenario Forecasts Reveal Vast Market Potential static version printer friendly pdf version
Pipeline and Commercial Insight: Parkinsons Disease - Market to grow as first round of lifecycle management strategies succeed static version printer friendly pdf version
Pipeline Insight: Multiple Sclerosis - The Oral Revolution static version printer friendly pdf version
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntingtons Disease static version printer friendly pdf version
Pipeline Insight: Schizophrenia static version printer friendly pdf version
Pipeline Report - Neuronal alpha 7 nicotinic receptors: Candidates for the treatment of Alzheimers disease and Schizophrenia static version printer friendly pdf version
Portfolio Management in CNS: Composite Portfolio Analysis of Eli Lilly and Novartis static version printer friendly pdf version
Pricing and Reimbursement Issues in Neurology static version printer friendly pdf version


^ Top



R

Reward and Decision Making in Corticobasal Ganglia Networks static version printer friendly pdf version


^ Top



S

Severe Dementia static version printer friendly pdf version
Sex Differences in the Brain: From Genes to Behavior static version printer friendly pdf version
Short Protocols in Neuroscience: Systems and Behavioral Method static version printer friendly pdf version
Stakeholder Opinion: Erectile Dysfunction - Identifying Product Differentiation and Patient Segmentation Strategies static version printer friendly pdf version
Stem Cell Therapeutics static version printer friendly pdf version
Strategic Analysis of World Emerging Neurological Therapeutics Markets static version printer friendly pdf version
Strategic Perspective 2001: Opioid Use in Pain Management static version printer friendly pdf version
Strategic Perspectives 2001: Neuropathic pain - Catch 22: high revenue potential but a high risk investment static version printer friendly pdf version
Strategic Perspectives 2002: CNS Disorders in Women - Urinary Incontinence static version printer friendly pdf version


^ Top



T

Target Product Profiles 2008: Physician Insights on Key Attributes - Diabetic Nephropathy static version printer friendly pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Multiple Sclerosis (Chronic-Progressive) static version printer friendly pdf version
The Brain Atlas: A Visual Guide to the Human Central Nervous System, 3rd Edition static version printer friendly pdf version
The CNS Market 2008 Report static version printer friendly pdf version
The CNS Market Outlook to 2010 static version printer friendly pdf version
The CNS Market Outlook to 2011 static version printer friendly pdf version
The CNS Market Outlook to 2012 static version printer friendly pdf version
The CNS Outlook to 2007 static version printer friendly pdf version
The Embryonic Human Brain: An Atlas of Developmental Stages, 3rd Edition static version printer friendly pdf version
The MAK Collection for Occupational Health and Safety: Part IV: Biomonitoring Methods, Volume 11 static version printer friendly pdf version
The Neurotechnology Industry 2008 Report: Drugs, Devices and Diagnostics for the Brain and Nervous System static version printer friendly pdf version
The Outlook For Niche CNS Disorders: Commercial Opportunities In Developing Markets static version printer friendly pdf version
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D static version printer friendly pdf version
Therapeutic Clinical Intelligence - Multiple Sclerosis Vol II static version printer friendly pdf version
Therapeutic Clinical Intelligence - Rheumatoid Arthritis static version printer friendly pdf version
Thought Leader Insight & Analysis: Alzheimer's Disease static version printer friendly pdf version
Thought Leader Insight & Analysis: Anxiety & Depression static version printer friendly pdf version
Top CNS Portfolios in 2004 - The Industry Gold Standards static version printer friendly pdf version
Treatment Algorithms 2001: Schizophrenia - The Rise of Atypical Neuroleptics as the Physicians’ Favorite static version printer friendly pdf version
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice static version printer friendly pdf version
Treatment-resistant depression: An untapped area of the patient population static version printer friendly pdf version
Trial TRAX - Multiple Sclerosis - Clinical Trial Monitoring Brief static version printer friendly pdf version


^ Top



U

U.S. Multiple Sclerosis Markets static version printer friendly pdf version
U.S. Neurological Devices Market - Investment Analysis static version printer friendly pdf version
U.S. Sales and Growth for Neurological Monitor SAM, 1998-2008 static version printer friendly pdf version
Update:The CNS Outlook 2000 static version printer friendly pdf version


^ Top



V

Vagus Nerve Stimulation: The potential impact on pharmacotherapy in epilepsy and mood disorders static version printer friendly pdf version

All rights reserved. © copyright 2006 Research and Markets
Terms and conditions Privacy Policy